Headline
The latest stories from AHA Today.
The National Bobblehead Hall of Fame and Museum has donated the first $100,000 from its sale of Dr. Fauci bobbleheads to the AHA 100 Million Mask Challenge’s Protect the Heroes fund, created to provide critical resources for frontline hospital caregivers.
CMS has delayed the start of its Emergency Triage, Treat, and Transport (ET3) Model from May 1 until fall 2020 as model participants work to respond to the needs of the COVID-19 emergency.
The AHA asked the Small Business Administration to make small- and mid-size public hospitals eligible for its newly-authorized Paycheck Protection Program.
UnitedHealth Group will accelerate nearly $2 billion in claims payments to U.S. health care providers under its fully insured commercial, Medicare Advantage and Medicaid businesses to address short-term financial pressure caused by the COVID-19 emergency, UnitedHealthcare and Optum announced.
The Centers for Medicare & Medicaid Services delivered close to $34 billion in Medicare accelerated and advance payments to Part A providers, including hospitals, and Part B suppliers to combat resource challenges related to COVID-19, the agency said.
The Creative Coalition, Association for Healthcare Philanthropy, and the AHA launched the “Protect the Heroes” campaign, which allows the general public to make direct impact donations to America’s hospitals and health systems.
The Food and Drug Administration recently issued an enforcement policy allowing certain modifications to expand the availability of devices used in extracorporeal membrane oxygenation therapy during the COVID-19 public health emergency.
To help health care professionals understand the potential risks and benefits of N95 respirator reuse or extended use during the COVID-19 emergency, ECRI updated its clinical evidence assessment on these practices.
AHA General Counsel Melinda Hatton and Jones Day lawyers Cathy Livingston and Robin Overby hosted a webinar on the Small Business Administration’s Paycheck Protection Program.
The Drug Enforcement Agency said it is increasing annual caps for controlled substances whose supplies are in high demand due the COVID-19 crisis.